380 related articles for article (PubMed ID: 32618497)
1. High neutralizing antibody titer in intensive care unit patients with COVID-19.
Liu L; To KK; Chan KH; Wong YC; Zhou R; Kwan KY; Fong CH; Chen LL; Choi CY; Lu L; Tsang OT; Leung WS; To WK; Hung IF; Yuen KY; Chen Z
Emerg Microbes Infect; 2020 Dec; 9(1):1664-1670. PubMed ID: 32618497
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.
Wu F; Liu M; Wang A; Lu L; Wang Q; Gu C; Chen J; Wu Y; Xia S; Ling Y; Zhang Y; Xun J; Zhang R; Xie Y; Jiang S; Zhu T; Lu H; Wen Y; Huang J
JAMA Intern Med; 2020 Oct; 180(10):1356-1362. PubMed ID: 32808970
[TBL] [Abstract][Full Text] [Related]
3. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
Marklund E; Leach S; Axelsson H; Nyström K; Norder H; Bemark M; Angeletti D; Lundgren A; Nilsson S; Andersson LM; Yilmaz A; Lindh M; Liljeqvist JÅ; Gisslén M
PLoS One; 2020; 15(10):e0241104. PubMed ID: 33085715
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients.
Deshpande GR; Sapkal GN; Tilekar BN; Yadav PD; Gurav Y; Gaikwad S; Kaushal H; Deshpande KS; Kaduskar O; Sarkale P; Baradkar S; Suryawanshi A; Lakra R; Sugunan AP; Balakrishnan A; Abraham P; Salve P
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):82-87. PubMed ID: 32859866
[TBL] [Abstract][Full Text] [Related]
5. Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
Bradfute SB; Hurwitz I; Yingling AV; Ye C; Cheng Q; Noonan TP; Raval JS; Sosa NR; Mertz GJ; Perkins DJ; Harkins MS
J Infect Dis; 2020 Oct; 222(10):1620-1628. PubMed ID: 32779705
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients.
Gozalbo-Rovira R; Gimenez E; Latorre V; Francés-Gómez C; Albert E; Buesa J; Marina A; Blasco ML; Signes-Costa J; Rodríguez-Díaz J; Geller R; Navarro D
J Clin Virol; 2020 Oct; 131():104611. PubMed ID: 32882666
[TBL] [Abstract][Full Text] [Related]
7. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection.
Lin Q; Zhu L; Ni Z; Meng H; You L
J Microbiol Immunol Infect; 2020 Oct; 53(5):821-822. PubMed ID: 32249185
[No Abstract] [Full Text] [Related]
8. Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
Chen X; Pan Z; Yue S; Yu F; Zhang J; Yang Y; Li R; Liu B; Yang X; Gao L; Li Z; Lin Y; Huang Q; Xu L; Tang J; Hu L; Zhao J; Liu P; Zhang G; Chen Y; Deng K; Ye L
Signal Transduct Target Ther; 2020 Sep; 5(1):180. PubMed ID: 32879307
[TBL] [Abstract][Full Text] [Related]
9. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
[TBL] [Abstract][Full Text] [Related]
10. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
[TBL] [Abstract][Full Text] [Related]
11. Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19.
Liu P; Cai J; Jia R; Xia S; Wang X; Cao L; Zeng M; Xu J
Emerg Microbes Infect; 2020 Dec; 9(1):1254-1258. PubMed ID: 32515685
[TBL] [Abstract][Full Text] [Related]
12. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
13. Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.
Kalkan Yazıcı M; Koç MM; Çetin NS; Karaaslan E; Okay G; Durdu B; Sümbül B; Doymaz MZ
J Immunol; 2020 Nov; 205(10):2719-2725. PubMed ID: 32978281
[TBL] [Abstract][Full Text] [Related]
14. Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study.
Yang C; Jiang M; Wang X; Tang X; Fang S; Li H; Zuo L; Jiang Y; Zhong Y; Chen Q; Zheng C; Wang L; Wu S; Wu W; Liu H; Yuan J; Liao X; Zhang Z; Shi X; Geng Y; Zhang H; Zheng H; Wan M; Lu L; Ren X; Cui Y; Zou X; Feng T; Xia J; Yang R; Liu Y; Mei S; Li B; Yang Z; Hu Q
Emerg Microbes Infect; 2020 Dec; 9(1):2368-2378. PubMed ID: 33151135
[TBL] [Abstract][Full Text] [Related]
15. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.
Jiang S; Hillyer C; Du L
Trends Immunol; 2020 May; 41(5):355-359. PubMed ID: 32249063
[TBL] [Abstract][Full Text] [Related]
17. Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma.
Yasuda H; Tsukune Y; Watanabe N; Sugimoto K; Uchimura A; Tateyama M; Miyashita Y; Ochi Y; Komatsu N
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):774-776. PubMed ID: 32933879
[No Abstract] [Full Text] [Related]
18. Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.
Kim YJ; Bae JY; Bae S; Hwang S; Kwon KT; Chang HH; Lee WK; Cui C; Lee GE; Kim SW; Park MS
Yonsei Med J; 2021 Jul; 62(7):584-592. PubMed ID: 34164955
[TBL] [Abstract][Full Text] [Related]
19. Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Rijkers G; Murk JL; Wintermans B; van Looy B; van den Berge M; Veenemans J; Stohr J; Reusken C; van der Pol P; Reimerink J
J Infect Dis; 2020 Sep; 222(8):1265-1269. PubMed ID: 32726417
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
